Brazil Company Requests Emergency Authorization To Use India's Covaxin

Brazil Company Requests Emergency Authorization To Use India's Covaxin

March 9, 2021, 7:38 a.m.

SAO PAULO/ Brazilian company Precisa Medicamentos, representing India’s Bharat Biotech, on Monday said it requested that the country’s health regulator, Anvisa, grant emergency authorization to use the Covaxin COVID-19 vaccine.

In addition, it said Covaxin would be trialed in a Phase Three study in Brazil carried out in partnership with Sao Paulo’s Albert Einstein hospital.

More on Health

The Latest

Latest Magazine

VOL. 14 No. 16, April 16, 2021 (Baisakh 03, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14 No. 15, April 02, 2021 (Chaitra 20, 2077) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14 No. 14, March 12, 2021 (Falgun 28, 2077) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14 No. 13, February 26, 2021 (Falgun 14, 2077) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75